Mirvaso Gel (Brimonidine 0.33%)

Mirvaso is the new FDA approved treatment from Galderma that was previously known as Sansrosa, CD07805/47 and Col-118. Mirvaso is the only topical treatment officially approved for the relief of the red face of rosacea. Mirvaso is Brimonidine Topical Gel 0.33% and is available in 30g and 45g tubes, on prescription only. It is used once per day and can last as long as 12 hours.

See below for Mirvaso User Reviews, news and updates

Recent Rosacea Blog Posts

Mirvaso Gel Coupon (Cost Reduction Card) now available

  As is the case for many of the prescriptions targeted at rosacea, the manufacturers of Mirvaso have made available a Mirvaso Coupon program. Galderma calls their Mirvaso campaign the Mirvaso Cost Reduction Card. The tagline for the promotion is “Eligible insured patients MAY pay no more than $50 for each Mirvaso Topical Gel prescription”. […]

Continue Reading

Mirvaso Patents to prohibit Generic Mirvaso

Galderma is claiming that the following patents protect their recently FDA Approved Brimonidine Gel known as Mirvaso. These patents are quoted in the Mirvaso Prescribing Information thus forming a public statement by Galderma to any would be competitors. Note one patent is for using Mirvaso to treat the broken blood vessels of rosacea (telangiectasis). This […]

Continue Reading

Will I have a Bad Reaction to Mirvaso?

Now that Mirvaso has been officially approved by the FDA, the final clinical trial results quoted to the FDA have become available. The Mirvaso Prescribing Information contains some statistics relating to the number and type of adverse reactions that occurred during the clinical trials. So if you are prescribed Mirvaso, what are your chances that […]

Continue Reading

Mirvaso Before and After Pictures

What sort of benefit might you expect from using Mirvaso to treat your rosacea redness? Well, Galderma has made available some publicity photographs that show before and after photographs from the Mirvaso Clinical Trials. These photographs also appeared in the journal of drugs in dermatology article describing the development and analysis of Mirvaso’s active ingredient […]

Continue Reading

Mirvaso Ingredients

The just approved Mirvaso is a milestone in the long development and approval process. Rosacea sufferers have watched this drug since as early as 2004 when patents started emerging. Now that Mirvaso has been officially approved by the FDA more information about the final formulation has emerged. From the Mirvaso Prescribing Information we can see […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.